Quotient Investors’s AbbVie ABBV Stock Holding History

Quotient Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$994K	Buy	11,191 +100	+0.9%	+$7.61K	0.68%	62
2017 Q2	$804K	Sell	11,091 -1,509	-12%	-$101K	0.57%	67
2017 Q1	$821K	Sell	12,600 -300	-2%	-$18.9K	0.5%	64
2016 Q4	$808K	Hold	12,900	–	–	0.51%	63
2016 Q3	$814K	Hold	12,900	–	–	0.53%	64
2016 Q2	$799K	Buy	12,900 +7,280	+130%	+$444K	0.38%	84
2016 Q1	$321K	Buy	5,620 +820	+17%	+$45.7K	0.12%	170
2015 Q4	$284K	Sell	4,800 -5,807	-55%	-$334K	0.11%	181
2015 Q3	$577K	Sell	10,607 -124,069	-92%	-$8.08M	0.13%	122
2015 Q2	$9.05M	Buy	134,676 +71,876	+114%	+$4.69M	1.24%	26
2015 Q1	$3.68M	Buy	62,800 +56,500	+897%	+$3.41M	0.5%	59
2014 Q4	$412K	Buy	+6,300	New	+$397K	0.08%	182
2014 Q3	–	Sell	-18,200	Closed	-$1.03M	–	238
2014 Q2	$1.03M	Hold	18,200	–	–	0.22%	140
2014 Q1	$935K	Buy	18,200 +7,500	+70%	+$379K	0.21%	136
2013 Q4	$565K	Buy	+10,700	New	+$526K	0.13%	166

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Quotient Investors's ABBV Position: Q3 2017 in Review

Quotient Investors increased its AbbVie (ABBV) stake by 0.9% in Q3 2017, buying an estimated $7.61K and bringing the position to 11,191 shares worth $994K. The position accounts for 0.68% of the portfolio, ranked #62.

Quotient Investors first reported a position in ABBV in Q4 2013 and has held it in 15 quarters since. The position peaked at $9.05M in Q2 2015. 1,798 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

Quotient Investors held 11,191 shares of AbbVie worth $994K as of Q3 2017.
Quotient Investors bought 100 AbbVie shares in Q3 2017, an estimated $7.61K.
AbbVie made up 0.68% of Quotient Investors's portfolio in Q3 2017, its #62 holding.
Quotient Investors first reported a position in AbbVie in Q4 2013 and has held it in 15 quarters since.
Quotient Investors's AbbVie position peaked at $9.05M in Q2 2015.
1,798 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.